Clinical Research Operations Flashcards

Question 1

What is a clinical trial in the context of clinical research operations?

Accepted Answer

A clinical trial is a planned prospective study in which participants are assigned to one or more interventions, and outcomes are measured to answer a defined research question. Operations teams plan, run, and close these studies so that the question can be answered reliably, safely, and in line with ethical and regulatory requirements.

Question 2

Why do sponsors and sites need a shared protocol before enrolling anyone?

Accepted Answer

A protocol is the master plan that describes the study objectives, design, eligibility criteria, procedures, and statistical analysis. Sponsors and sites need it agreed in advance so that everyone collects the same data in the same way, and so that changes are reviewed and approved before they affect participants.

Question 3

What is the difference between a sponsor and an investigator in a clinical study?

Accepted Answer

The sponsor is the person, company, or institution that initiates, funds, and takes overall responsibility for a study. The investigator is the individual who conducts the study at a site and is responsible for the care and safety of participants there.

Question 4

How are clinical development phases typically organized, and how does the purpose of each phase change?

Accepted Answer

Clinical development is usually described in phases. Early phase studies focus on initial safety, dosing, or feasibility in small groups. Later phases enroll larger numbers to confirm effectiveness, monitor adverse events, and compare against existing options. Post-approval studies continue to gather information once products are in use.

Question 5

What is a control group, and why do many studies include one?

Accepted Answer

A control group is a set of participants who do not receive the experimental intervention, or who receive a standard or placebo comparator. Including one allows investigators to separate the effect of the intervention from changes that would have happened anyway, such as natural change over time.

Question 6

What is randomization, and what problem does it help prevent?

Accepted Answer

Randomization is a process that assigns participants to study groups by chance rather than by investigator choice or participant preference. It helps prevent selection bias, which can occur when healthier or more motivated people are placed in one group.

Question 7

What does blinding mean, and why might a study use single or double blinding?

Accepted Answer

Blinding means keeping certain people unaware of which study group a participant has been assigned to. Single blinding usually hides assignment from participants, while double blinding hides it from both participants and the people assessing outcomes or delivering care. Blinding reduces bias in how people behave or record results.

Question 8

What is a primary endpoint, and how does it differ from a secondary endpoint?

Accepted Answer

A primary endpoint is the outcome measure the study is designed to answer, and it determines the main sample size and analysis plan. Secondary endpoints are additional outcomes that add context or support the main question but are usually not the basis for the central conclusion.

Question 9

What is Good Clinical Practice, and who does it mainly guide?

Accepted Answer

Good Clinical Practice is an international ethical and scientific quality standard for designing, conducting, recording, and reporting studies that involve people. It is intended to protect participant rights, safety, and wellbeing and to ensure that trial data are credible. It guides sponsors, investigators, and everyone else who contributes to a study.

Question 10

What is the role of an institutional review board or independent ethics committee?

Accepted Answer

An institutional review board, or independent ethics committee, is a group that must approve a study protocol, consent form, and recruitment materials before the study starts at a site. It also reviews safety reports and ongoing changes, and it can require modifications or stop a study.

Question 11

Why must a sponsor notify or obtain authorization from a regulatory authority before a study starts?

Accepted Answer

Authorization lets a regulatory agency confirm that a proposed study is scientifically sound and ethically acceptable before participants are enrolled. Requirements vary by country and by product type, but the general purpose is public protection. Sponsors must follow submission rules and answer questions before proceeding.

Question 12

What is the difference between an audit and a monitoring visit?

Accepted Answer

A monitoring visit is a routine check by a sponsor or contracted monitor to confirm that a site follows the protocol and records data accurately. An audit is a more formal, independent examination of study conduct and records, often prompted by a specific concern.

Question 13

Why are source documents considered important for regulatory inspections and data credibility?

Accepted Answer

Source documents are the original records where study information is first captured, such as clinic notes, laboratory reports, and worksheets. Inspectors compare case report entries against these originals to confirm that reported data are accurate, complete, and attributable. Clear, contemporaneous records give confidence that results reflect what actually happened.

Question 14

What do the core ethical principles of respect for persons, beneficence, and justice mean in research?

Accepted Answer

The three core principles are respect for persons, beneficence, and justice, which are widely taught as the foundation of research ethics. Respect for persons means honoring individual autonomy and protecting people with reduced capacity. Beneficence means minimizing harm and maximizing possible benefit. Justice means fairly distributing research burdens and benefits across groups.

Question 15

What is a trial master file, and why must it be kept complete?

Accepted Answer

The trial master file is the collection of essential documents that allow a study's conduct and data to be evaluated. It typically includes the protocol, approvals, signed agreements, training records, and investigator qualifications. Keeping it complete and current supports inspections and demonstrates compliance.

Question 16

What happens when a serious unexpected safety event is reported during a study?

Accepted Answer

A serious unexpected safety event triggers a defined reporting process rather than informal handling. The investigator notifies the sponsor promptly and the sponsor evaluates the event. It reports the event to regulatory authorities and ethics committees as required. Oversight bodies then decide whether changes to consent, procedures, or the protocol are needed.

Question 17

What is a feasibility assessment, and why is it done before a study starts?

Accepted Answer

A feasibility assessment checks whether a planned study can realistically be carried out at a proposed site. It considers patient population size, staff capacity, equipment, prior study experience, competing studies, and local regulatory timelines. Completing it early helps sponsors choose sites that can enroll and manage participants well.

Question 18

What is a clinical trial agreement, and what does it typically cover?

Accepted Answer

A clinical trial agreement is a contract between the sponsor and the site that sets out the responsibilities of each party. It usually covers the scope of work, payment terms, budget, publication rights, insurance, confidentiality, and how data and intellectual property are handled. Clear agreements prevent disputes and protect both parties.

Question 19

What is site selection in study planning, and which factors matter most?

Accepted Answer

Site selection is the process of choosing research locations likely to meet the study's enrollment, quality, and compliance needs. Important factors include access to eligible participants, investigator experience, staff availability, facilities, record systems, and a track record of timely accurate work.

Question 20

What is an investigator site file, and what should it contain?

Accepted Answer

The investigator site file is the set of study documents kept at a research site to show the trial was conducted properly there. It typically holds the protocol, approvals, signed agreements, financial disclosures, training logs, delegation of duties, and copies of correspondence with the sponsor.

Question 21

What is a delegation of duties log, and why is it required?

Accepted Answer

A delegation of duties log lists each staff member, the tasks they are authorized to perform, and their training dates. It shows that tasks were assigned deliberately and performed only by qualified people. The investigator remains responsible for overseeing all delegated work.

Question 22

What are the main activities during study initiation at a site?

Accepted Answer

Study initiation typically includes staff training on the protocol, setup of records and systems, confirmation of approvals, and checks that supplies and equipment are ready. It often ends with a site initiation visit and formal activation. Only after activation can the site enroll participants.

Question 23

What is a site activation, and why is it a distinct milestone?

Accepted Answer

Site activation is the formal point at which a site is confirmed ready to begin enrolling participants under the protocol. Confirmation typically requires approvals in place, trained staff, and operational documents and systems. Marking it clearly helps sponsors track readiness across many sites and avoids enrollment before preparation is complete.

Question 24

How do sponsors and sites handle protocol amendments once a study is running?

Accepted Answer

A protocol amendment is a formal change to the study plan, and it must be written, justified, reviewed by the ethics committee, and approved by the regulatory authority where required before the change is implemented.

Question 25

What are eligibility criteria, and why are inclusion and exclusion criteria both needed?

Accepted Answer

Eligibility criteria are the defined characteristics that determine who may join a study. Inclusion criteria state the characteristics a person must have, while exclusion criteria list conditions that rule a person out. Both are needed so that the study population matches the research question and participant safety is considered.

Question 26

What is informed consent, and what elements should a consent process include?

Accepted Answer

Informed consent is the voluntary, ongoing process by which a person learns about a study and decides whether to take part. A proper process explains the purpose, procedures, risks, potential benefits, alternatives, confidentiality, and the right to withdraw at any time without penalty.

Question 27

Why must consent be obtained before any study procedure is performed?

Accepted Answer

Consent must come first because participation has to be a free choice made with adequate information. That choice cannot be made after a person has already been exposed to study procedures. Research-only procedures must wait until the person has agreed.

Question 28

What is a recruitment strategy, and what ethical limits apply to it?

Accepted Answer

A recruitment strategy is the plan for identifying, contacting, and informing potential participants about a study. Common approaches include clinic referrals, registries, community outreach, and advertisements. Ethical limits require that recruitment be honest, avoid undue inducements or pressure, protect privacy, and never exploit vulnerability.

Question 29

What makes participant payment or reimbursement in research ethically acceptable?

Accepted Answer

Reimbursement for real expenses, such as travel and parking, is widely viewed as acceptable, while payment should not be large enough to encourage people to take risks they would otherwise decline. Payment amounts and schedules should be reviewed by the ethics committee and described in the consent document.

Question 30

What is a screening log, and why do sponsors and sites keep one?

Accepted Answer

A screening log records every person who was assessed for eligibility, including whether they enrolled and, if not, why. It shows that recruitment was conducted fairly and that enrolled participants were not selected in ways that bias results. Sponsors use it to evaluate recruitment performance.

Question 31

What does retention mean in a clinical study, and why does it matter?

Accepted Answer

Retention refers to keeping enrolled participants in the study through its planned schedule of visits and assessments. It matters because missing data from participants who drop out can weaken conclusions and can introduce bias if dropouts differ from those who stay. Good retention planning includes reminders and clear communication.

Question 32

What should happen when a participant decides to withdraw from a study?

Accepted Answer

A participant may withdraw at any time without penalty or loss of routine care. The site should document the withdrawal, record the reason if the participant provides one, and clarify what happens to data already collected and to any ongoing follow-up. Sites should not pressure people to stay.

Question 33

What is a case report form, and what purpose does it serve?

Accepted Answer

A case report form is the structured document, paper or electronic, used to record each participant's study data. It standardizes what is collected and how it is formatted, so data from many sites can be combined and analyzed consistently. Entries should always trace back to source records.

Question 34

What is a data query, and how is it typically resolved?

Accepted Answer

A data query is a question raised when a data point appears missing, inconsistent, or out of range. It is sent to the site, which checks the source record and then either corrects the entry or explains the value. Queries are tracked until closed.

Question 35

What is an audit trail in an electronic data capture system?

Accepted Answer

An audit trail is a secure, time-stamped record of who entered, changed, or deleted data, and why. It lets reviewers reconstruct the history of any data point without overwriting earlier entries. Audit trails support data integrity, which is a core expectation in regulated research.

Question 36

What is data integrity, and what do the ALCOA principles describe?

Accepted Answer

Data integrity means that data are complete, consistent, accurate, and trustworthy throughout their lifecycle. The ALCOA principles describe this as data being attributable, legible, contemporaneous, original, and accurate, with later expanded versions adding complete, consistent, enduring, and available. These expectations apply to paper and electronic records alike.

Question 37

What is risk-based monitoring, and how does it differ from full source data verification?

Accepted Answer

Risk-based monitoring focuses oversight on the data and processes that matter most for participant safety and result reliability. It combines central review with targeted site visits. Full source data verification, by contrast, compares every case report entry against source records. It directs effort where errors would have the greatest impact.

Question 38

What is a monitoring plan, and what should it specify?

Accepted Answer

A monitoring plan is the written strategy describing who oversees a study, how often visits occur, and what is checked. It should also set escalation criteria, how findings are reported and followed up, and how oversight intensity responds to risk. Each version should be approved and version controlled.

Question 39

What is a protocol deviation, and how should it be handled?

Accepted Answer

A protocol deviation is any departure from the approved protocol, whether unintentional or intentional. Deviations should be documented promptly, assessed for their impact on participant safety and data quality, and reported as the sponsor and ethics committee require. Recurring or serious deviations may lead to corrective actions and additional training.

Question 40

What is a corrective and preventive action plan, and when is one used?

Accepted Answer

A corrective and preventive action plan, or CAPA, is a documented process for finding the cause of a quality problem, fixing it, and preventing recurrence. It is used when audits, monitoring, or internal reviews reveal significant errors, deviations, or system weaknesses. A good plan names responsible people, deadlines, and how effectiveness will be checked.

Clinical Research Operations Flashcards

1Foundations of Clinical Research

2Regulatory and Ethical Framework

3Study Start-Up and Site Management

4Recruitment, Consent and Retention

5Data Management and Quality Systems

Learning Resources